Ketamine for PTSD: The Emerging Evidence and Clinical Protocol

Post-traumatic stress disorder (PTSD) is one of the most debilitating psychiatric conditions — and one of the hardest to treat. Standard first-line treatments, including SSRIs and trauma-focused psychotherapy, leave a substantial portion of patients with persistent, life-disrupting symptoms.

Ketamine therapy is emerging as one of the most promising new approaches for PTSD, with clinical research showing rapid, significant reductions in both PTSD symptoms and the depression that so often accompanies them.

At Roth Family Medicine & Mental Health in Pocatello, Idaho, we offer ketamine-assisted therapy for patients with PTSD, treatment-resistant depression, and other conditions that haven't responded adequately to conventional treatments.

PTSD develops after exposure to traumatic events — combat, sexual assault, accidents, childhood abuse, medical trauma, or any experience that overwhelms the nervous system's capacity to process and integrate what happened.

The core features of PTSD include:

• Intrusion symptoms: Flashbacks, nightmares, intrusive memories
• Avoidance: Avoiding trauma reminders, emotional numbing, detachment
• Negative cognitions and mood: Distorted beliefs about self and world, persistent negative emotions, guilt, shame
• Hyperarousal: Hypervigilance, exaggerated startle response, sleep disturbance, irritability

What makes PTSD particularly difficult to treat is that it involves deep structural and functional changes in the brain — particularly in the amygdala (fear center), hippocampus (memory), and prefrontal cortex (rational thinking and emotional regulation). These changes can persist for years or decades after the traumatic event.

Standard SSRIs (sertraline and paroxetine are FDA-approved for PTSD) help some patients but leave many with significant residual symptoms. Trauma-focused therapies like EMDR and Prolonged Exposure are effective but require patients to repeatedly engage with traumatic memories — which many patients find intolerable or are unable to complete.

Ketamine's mechanism of action is fundamentally different from SSRIs and other conventional psychiatric medications. Rather than slowly adjusting serotonin or norepinephrine levels over weeks, ketamine works through the glutamate system — the brain's primary excitatory neurotransmitter — producing rapid and dramatic effects on neural plasticity.

Ketamine triggers a rapid burst of BDNF (brain-derived neurotrophic factor) and activates the mTOR pathway, leading to rapid formation of new synaptic connections in the prefrontal cortex. This process — called synaptogenesis — essentially rebuilds neural circuits that have been damaged or pruned by chronic stress and trauma.

One of the most exciting areas of ketamine research in PTSD involves fear memory reconsolidation. When traumatic memories are recalled, they briefly become malleable before being "re-stored." Ketamine, administered during this reconsolidation window, may disrupt the re-storage of fear memories — essentially weakening the emotional charge attached to traumatic memories.

The mild dissociative state produced by ketamine may itself be therapeutic for PTSD. By temporarily disrupting the usual associations between trauma cues and fear responses, ketamine may create a window in which patients can process traumatic material with less overwhelming emotional reactivity.

PTSD is associated with elevated neuroinflammation, and ketamine has significant anti-inflammatory properties in the brain. Reducing neuroinflammation may contribute to ketamine's therapeutic effects in PTSD.

The evidence base for ketamine in PTSD has grown substantially in recent years:

2014 — First RCT: A randomized controlled trial published in JAMA Psychiatry found that a single IV ketamine infusion produced significant, rapid reductions in PTSD symptom severity compared to midazolam (active placebo), with effects lasting up to two weeks.

2021 — Multiple infusions: A study published in Neuropsychopharmacology found that a series of six ketamine infusions produced substantial reductions in PTSD symptoms, with 67% of patients achieving clinically meaningful improvement.

2022 — Ketamine + psychotherapy: Emerging research combining ketamine with trauma-focused psychotherapy (ketamine-assisted psychotherapy, or KAP) shows particularly promising results, with the neuroplasticity window created by ketamine potentially enhancing the effectiveness of subsequent therapy sessions.

Military and veteran populations: Multiple studies in combat veterans with PTSD have shown significant symptom reduction with ketamine, including in patients who had failed multiple prior treatments.

Comorbid depression: Because PTSD and depression so frequently co-occur, ketamine's well-established antidepressant effects provide additional benefit for many PTSD patients.

Our ketamine protocol for PTSD is individualized based on each patient's history, symptom profile, and treatment goals. Here's what the process typically looks like:

Before beginning ketamine therapy, every patient undergoes a comprehensive evaluation including:

• Full psychiatric history and PTSD symptom assessment (PCL-5 scale)
• Medical history and physical examination
• Review of prior treatments and responses
• Discussion of expectations, risks, and benefits
• Coordination with existing mental health providers when applicable

For PTSD, we typically recommend a series of six ketamine infusions administered over 2–3 weeks. This protocol is based on the strongest evidence from clinical trials and our clinical experience.

Each infusion session:

• Duration: 40–60 minutes
• Setting: Private, comfortable treatment room with monitoring
• Preparation: Patients are encouraged to set an intention for the session
• Integration: Brief check-in after each session; full integration support available

Ketamine for PTSD is typically administered at sub-anesthetic doses (0.5 mg/kg IV over 40 minutes is the most studied protocol). Doses may be adjusted based on individual response and tolerability.

The neuroplasticity window following ketamine treatment — typically 24–72 hours — is a critical period for integration. We encourage patients to:

• Engage in trauma-focused therapy during this window when possible
• Practice mindfulness and journaling
• Avoid alcohol and recreational substances
• Prioritize sleep and gentle physical activity

After the initial series, some patients benefit from periodic maintenance infusions (monthly or as needed) to sustain their gains. We work with each patient to develop an individualized maintenance plan.

Ketamine therapy for PTSD may be appropriate if you:

• Have a diagnosis of PTSD (or significant trauma-related symptoms)
• Have tried at least one or two standard treatments (SSRIs, therapy) without adequate relief
• Are experiencing significant functional impairment from PTSD symptoms
• Have comorbid treatment-resistant depression
• Are medically stable and do not have contraindications to ketamine

Contraindications to ketamine therapy include uncontrolled hypertension, active psychosis, certain cardiac conditions, active substance use disorder (particularly dissociatives), and pregnancy. A thorough medical evaluation will identify any contraindications before treatment begins.

Ketamine's primary advantage is speed of onset — for patients in acute distress or with severe functional impairment, waiting 4–8 weeks for an SSRI to work is not always acceptable. Ketamine can produce meaningful symptom relief within hours to days.

PTSD rarely travels alone. At our clinic, we frequently see PTSD co-occurring with:

• Major depressive disorder (present in ~50% of PTSD patients)
• Anxiety disorders (generalized anxiety, panic disorder, social anxiety)
• Substance use disorders (often self-medication)
• Chronic pain (trauma and pain share overlapping neural circuits)
• Sleep disorders (insomnia, nightmares, sleep apnea)
• Traumatic brain injury (particularly in veterans)

Ketamine's broad mechanism of action — affecting glutamate, BDNF, neuroinflammation, and neural plasticity — means it often addresses multiple comorbid conditions simultaneously, which is a significant advantage over condition-specific treatments.

At Roth Family Medicine & Mental Health, we approach PTSD treatment with deep respect for the complexity of trauma and the courage it takes to seek help. Our clinic environment is designed to be safe, calm, and non-triggering. We take time to understand each patient's trauma history, triggers, and needs before beginning any treatment.

Ketamine therapy is not a magic cure — it is a powerful tool that works best when embedded in a comprehensive, trauma-informed treatment plan that may include therapy, lifestyle support, and other interventions. We work collaboratively with patients and their existing mental health providers to ensure coordinated, effective care.

If you're in Pocatello, Chubbuck, Bannock County, or Southeast Idaho and you're living with PTSD that hasn't responded adequately to standard treatments, ketamine therapy may offer the relief you've been looking for.

Call us at (208) 904-4705 or book a consultation online. We'll take the time to understand your history, answer your questions, and help you determine whether ketamine therapy is right for you.

You don't have to keep living with the weight of trauma. Effective treatment is available — and it may work faster than you think.

• PTSD involves deep neurobiological changes that standard SSRIs often fail to fully address
• Ketamine works through the glutamate system, producing rapid neuroplasticity and fear memory reconsolidation
• Clinical trials show significant PTSD symptom reduction within 24–72 hours of ketamine treatment
• A series of six infusions over 2–3 weeks is the standard protocol for PTSD
• Ketamine works best when combined with trauma-focused psychotherapy during the neuroplasticity window
• Roth Family Medicine & Mental Health offers ketamine therapy for PTSD in Pocatello, Idaho

Kyle Roth, FNP-BC, APRN, MSN, MHA is a board-certified family nurse practitioner specializing in treatment-resistant depression, PTSD, ketamine therapy, and TMS therapy at Roth Family Medicine & Mental Health in Pocatello, Idaho.

This article is for informational purposes only and does not constitute medical advice. Ketamine therapy should only be administered under the supervision of a qualified medical provider.